DNAtrix to Present at the Raymond James Human Health Innovations Conference
News provided by
Share this article
Share this article
HOUSTON, June 9, 2021 /PRNewswire/ DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced that the company will present at the Raymond James Human Health Innovations Conference on Monday, June 21, 2021, at 1:20 pm ET.
A live webcast of the presentation is available for access in the Newsroom section of DNAtrix s website at https://www.dnatrix.com/newsroom/. An archived replay of the presentation will be available for 30 days following the day of the event.
About DNAtrix
DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its proprietary adenovirus platform is based on an engineered version of the common cold virus that is designed to selectively infect and kill cancer cells while leaving healthy cells unharmed. The company s lead product candidate is DNX-24